Moderna Covid-19 Vaccine Submitted For Authorization In Adolescents
Source: Wall Street Journal
Moderna Inc. said Thursday it has asked U.S. health regulators to authorize the use of its Covid-19 shot in adolescents ages 12 to 17, setting up the potential availability of a second vaccine option for adolescents.
The application means Moderna’s vaccine could be cleared for use in the older children this summer.
Moderna is seeking authorization from the U.S. Food and Drug Administration after releasing results of a study in May showing that the vaccine safely induced immune response in adolescents and appeared to be protective against Covid-19 disease.
“We are encouraged that the Moderna Covid-19 vaccine was highly effective at preventing Covid-19 and SARS-CoV-2 infection in adolescents,” Moderna Chief Executive Stephane Bancel said.
Read more: https://www.msn.com/en-us/health/medical/moderna-covid-19-vaccine-submitted-for-authorization-in-adolescents/ar-AAKUC6I?li=BBnb7Kz
